Key Highlights
- DraftKings' second-quarter Revenue fell about 5% to $1.443 billion, and the company swung to a net loss amid customer-friendly sports outcomes and heavier promotions.
- Melco Resorts' second-quarter Operating Revenue fell about 6% to $1.25 billion, reflecting continued Macau softness.
- Kura Sushi grew fiscal third-quarter total sales 16.1% to $85.9 million through new units, even as comparable sales slipped 0.4%.
- WW International, formerly WeightWatchers, is the most dramatic turnaround here, having emerged from Chapter 11 Bankruptcy in June 2025 after cutting roughly $1.15 billion of debt.
Consumer services is not one story in September 2026. It is a cluster of overlapping ones, leisure travel in China, gaming in Macau, regulated betting in the United States, restaurant expansion and the wellness industry's messy collision with GLP-1 weight-loss drugs. Because the Nasdaq Composite includes essentially every common stock and American depositary receipt listed on the exchange, all five companies below sit inside that index by virtue of their listing, even though none is large enough to move it on its own.
Tuniu (NASDAQ:TOUR), Melco Resorts (NASDAQ:MLCO), DraftKings (NASDAQ:DKNG), Kura Sushi (NASDAQ:KRUS) and WW International (NASDAQ:WW) span that range. Read together, though, they form a useful cross-section.
A Sector Pulled in Opposite Directions
The macro backdrop cuts both ways. Post-pandemic travel Demand in Asia has normalised rather than boomed, pressuring online-travel margins. Macau's gaming recovery has proved uneven, with mass-market resilience offset by softer high-end play. US online betting keeps expanding its addressable population state by state, but "customer-friendly" sporting results and heavier promotion can swing quarterly Economics violently. Restaurant operators are wrestling with traffic that has turned negative even where sales rise on price. And the wellness industry is being reshaped by GLP-1 medications that both threaten legacy diet models and open a clinical-subscription opportunity.
These are the currents against which each of the five must swim.
Tuniu (NASDAQ:TOUR): A Small Chinese Travel Platform Grinding Toward Consistency
Tuniu Corporation (NASDAQ:TOUR) is a Chinese online leisure-travel operator that trades as an ADR. For the second quarter of 2026, Tuniu reported net revenues of RMB138.9 million (about US$20.5 million), up 3.0% year over year, according to the company's results release. Its packaged-tour business, the core, grew 6.8% to RMB121.1 million, while other revenues fell 16.9%.
Profitability remains slim but positive: GAAP Net Income of roughly RMB0.3 million, and non-GAAP net income of RMB1.9 million. Management said the quarter marked its sixth consecutive quarter of non-GAAP profitability. For the third quarter of 2026, Tuniu guided to net revenues of RMB202.1 million to RMB212.2 million, implying 0% to 5% growth over the prior-year period. The story here is discipline over scale. Tuniu is a micro-cap operating in a market dominated by far larger platforms, and its appeal rests on repeated, if thin, profitability rather than growth heroics. Risks ahead include soft Chinese discretionary spending, currency translation and the challenge of expanding margins when core revenue growth sits in the low single digits.
Melco Resorts (NASDAQ:MLCO): Macau Softness, Regional Resilience
Melco Resorts & Entertainment (NASDAQ:MLCO), an ADR-listed casino and resort operator, posted total operating revenues of $1.25 billion for the second quarter of 2026, down about 6% from $1.33 billion a year earlier, per its results. Net income was $22.7 million, or $0.06 per ADS. Adjusted property EBITDA fell to $303.8 million from $377.7 million.
The pressure was concentrated in Macau. City of Dreams Macau revenue slipped to $632.2 million with EBITDA of $147.8 million, and Studio City also softened. The offset came from abroad: City of Dreams Mediterranean in Cyprus grew revenue to $82.0 million with EBITDA up roughly 60% to $19.9 million, while City of Dreams Manila edged EBITDA higher to $30.9 million. Melco repurchased 22.4 million ADSs for about $120.6 million between April and August 2026, leaving $589.6 million of authorisation, and reported available Liquidity of $2.80 billion. Melco is leaning on Capital returns and geographic Diversification while Macau normalises. The phased opening of its new REM hotel, flagged for the third quarter of 2026, is the near-term catalyst to watch. Macau visitation and high-margin play remain the swing factor, and Buybacks cannot indefinitely mask EBITDA declines.
DraftKings (NASDAQ:DKNG): Volume Up, Economics Squeezed
DraftKings Inc. (NASDAQ:DKNG) is the closest thing this group has to a household US name. For the second quarter of 2026 it reported revenue of $1.443 billion, down about 5% year over year, which management attributed to customer-friendly sport outcomes and increased promotional reinvestment. The company swung to a net loss of $67.6 million from net income of $157.9 million a year earlier, and adjusted EBITDA fell to $114.6 million from $300.6 million.
The underlying customer trend was healthier than the headline: monthly unique payers rose about 9% to 3.6 million, even as average revenue per payer fell roughly 13% to $132. DraftKings maintained full-year 2026 guidance of $6.5 billion to $6.9 billion in revenue and $700 million to $900 million in adjusted EBITDA. It is live with mobile sports betting in 27 states plus Washington, D.C. And Puerto Rico, about 53% of the US population, and its iGaming product operates in five states. Management said its Predictions product, launched in December 2025, is growing faster than anticipated. The quarter is a reminder that sportsbook results are inherently lumpy; a bad run of favourites for bettors flatters customers and punishes the house. The bull case rests on rising payers and new verticals such as prediction markets; the bear case, hedged, centres on promotional intensity, tax changes and outcome volatility.
Kura Sushi (NASDAQ:KRUS): Growth by Store Count, Not Same-Store Traffic
Kura Sushi USA (NASDAQ:KRUS) operates conveyor-belt sushi restaurants and remains one of the faster-expanding small-cap US chains. In its fiscal third quarter of 2026, total sales rose 16.1% to $85.9 million, driven by new units. Comparable restaurant sales, however, slipped 0.4%, as a 5.1% decline in traffic outweighed a 4.7% positive contribution from price and mix.
Net income was $0.4 million, or $0.03 per diluted share, down from $0.6 million a year earlier, while restaurant-level operating profit Margin improved to 19.1% from 18.2%, reaching $16.4 million. Kura opened seven restaurants in the quarter and operated 91 at period-end. Full-year fiscal 2026 guidance calls for sales of $330.5 million to $331.5 million and 16 new restaurants, keeping unit growth above 20%. Kura is a classic unit-growth story, and the tension is visible, top-line expansion is healthy, but negative traffic at existing stores is the metric to watch closely, because a growth chain leaning on price to hold comparable sales is vulnerable if consumer patience with menu Inflation wears thin. Margin improvement is the encouraging counterweight. The main risk ahead is labour and Commodity costs, plus the execution demands of opening at this pace.
WW International (NASDAQ:WW): Restructured, Relisted and Reinventing
WW International (NASDAQ:WW) is the most dramatic turnaround in the group. The former WeightWatchers filed for Chapter 11 bankruptcy in May 2025 and was Delisted from Nasdaq, trading over the counter, before emerging on 24 June 2025 in a restructuring that cut roughly $1.15 billion of Debt and returned the shares to Nasdaq under the ticker WW.
The rebuilt Business is pivoting hard toward clinical weight management. In the first quarter of 2026 it reported revenue of $168.3 million, down 9.8%, with a net loss of $52.0 million, though clinical subscription revenue grew to $38.8 million. According to aggregated reporting of its second-quarter 2026 results, revenue was $162.3 million, clinical subscription revenue rose about 30% to $39.9 million, clinical subscribers climbed roughly 56% to about 197,000, and the company returned to positive net income and reaffirmed full-year revenue guidance in the $620 million to $635 million range. WW is trying to convert the GLP-1 threat into a distribution advantage, wrapping medication access inside a subscription. The debt load is lighter but still carries a high interest rate. Looking ahead, the clinical pivot is showing early traction, but declining legacy membership and competition from well-funded telehealth rivals make the durability of the turnaround the central question.
What Investors Should Watch
Through the third and fourth quarters of 2026, the concrete catalysts are identifiable. For Tuniu, whether it can hold non-GAAP profitability while Chinese travel spending stays subdued. For Melco, Macau visitation trends and the ramp of the REM hotel. For DraftKings, football-season hold percentages, promotional discipline and the scaling of Predictions and iGaming. For Kura Sushi, whether negative traffic stabilises as pricing normalises. For WW, the trajectory of clinical subscribers against legacy attrition.
Cutting across all five: the direction of interest rates and the health of discretionary consumer spending, which set the ceiling for travel, gaming, betting, dining out and paid wellness alike.
Five Pressure Points in the 2026 Consumer
These are five small-to-mid-cap consumer names, not index bellwethers. What makes them worth reading together is that each isolates a different pressure point in the 2026 consumer: normalising Asian travel, uneven Macau gaming, volatile US betting economics, restaurant traffic under price strain and a wellness industry remade by GLP-1 drugs. The verifiable results point to a consumer who is still spending, but selectively, and to management teams leaning on new units, new products and new markets to grow where old engines have slowed.






Please wait processing your request...